Bad News for the Drug and Device Industries: Glaxo’s Systemic Breakdown in China (Part I of III)
Mark Twain, one of my favorite authors, always said it best – “Do the right thing. It will gratify some people and astonish the rest.” For drug and device companies, Mark Twain’s observation is becoming the industry standard. Since 2009, the drug and device industry has been the proverbial punching bag for FCPA enforcement. While the overall numbers are less than the major FCPA cases...